NCT00789191 - Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes | Biotech Hunter

Enrollment

222

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

The detemir insulin dose is injected subcutaneously (under the skin) once daily in the evening and will be titrated (individually adjusted) weekly throughout the trial.

DRUG

sitagliptin

The sitagliptin dose is 100 mg/ day and should be kept stable throughout the trial. Frequency of sitagliptin is once daily.

DRUG

metformin

Metformin treatment with at least 1000 mg/ day. Dose and dosing frequency should remain unchanged throughout the trial.

DRUG

sulphonylurea

Sulphonylurea (SU) dose and dosing frequency should initially remain unchanged. In case of hypoglycaemia SU dose may be reduced at the discretion of the investigator.

Trial Locations (51)

1083

Novo Nordisk Investigational Site, Budapest

1125

Novo Nordisk Investigational Site, Budapest

3300

Novo Nordisk Investigational Site, Eger

7623

Novo Nordisk Investigational Site, Pécs

11108

Novo Nordisk Investigational Site, Narbonne

14224

Novo Nordisk Investigational Site, West Seneca

19401

Novo Nordisk Investigational Site, Norristown

29200

Novo Nordisk Investigational Site, Brest

30338

Novo Nordisk Investigational Site, Dunwoody

34098

Novo Nordisk Investigational Site, Istanbul

34390

Novo Nordisk Investigational Site, Istanbul

35209

Novo Nordisk Investigational Site, Vestavia Hills

37411

Novo Nordisk Investigational Site, Chattanooga

41380

Novo Nordisk Investigational Site, Kocaeli

45245

Novo Nordisk Investigational Site, Cincinnati

45439

Novo Nordisk Investigational Site, Dayton

57950

Novo Nordisk Investigational Site, Montigny-lès-Metz

59037

Novo Nordisk Investigational Site, Lille

59100

Novo Nordisk Investigational Site, Roubaix

71200

Novo Nordisk Investigational Site, Le Creusot

75246

Novo Nordisk Investigational Site, Dallas

76100

Novo Nordisk Investigational Site, Pieksämäki

85295

Novo Nordisk Investigational Site, La Roche-sur-Yon

90404

Novo Nordisk Investigational Site, Santa Monica

92869

Novo Nordisk Investigational Site, Orange

98401

Novo Nordisk Investigational Site, Lučenec

V3K 3P4

Novo Nordisk Investigational Site, Coquitlam

V3L 3W5

Novo Nordisk Investigational Site, New Westminster

A1A 3R5

Novo Nordisk Investigational Site, St. John's

N1R 7L6

Novo Nordisk Investigational Site, Cambridge

L2E 7H1

Novo Nordisk Investigational Site, Niagara Falls

M3J 1N2

Novo Nordisk Investigational Site, Toronto

M9W 4L6

Novo Nordisk Investigational Site, Toronto

G6W 5M6

Novo Nordisk Investigational Site, Saint Romuald

J1H 4J6

Novo Nordisk Investigational Site, Sherbrooke

L2G 5X7

Novo Nordisk Investigational Site, Niagara Falls

FI-00350

Novo Nordisk Investigational Site, Helsinki

FI-32200

Novo Nordisk Investigational Site, Loimaa

FI-90220

Novo Nordisk Investigational Site, Oulu

FI-28100

Novo Nordisk Investigational Site, Pori

FI-60100

Novo Nordisk Investigational Site, Seinäjoki

H-1212

Novo Nordisk Investigational Site, Budapest

831 01

Novo Nordisk Investigational Site, Bratislava

851 01

Novo Nordisk Investigational Site, Bratislava

040 01

Novo Nordisk Investigational Site, Košice

080 01

Novo Nordisk Investigational Site, Prešov

01001

Novo Nordisk Investigational Site, Žilina

705-717

Novo Nordisk Investigational Site, Daegu

400-103

Novo Nordisk Investigational Site, Incheon

135-239

Novo Nordisk Investigational Site, Seoul

06100

Novo Nordisk Investigational Site, Ankara